NEWS DETAIL

Stellungnahme/Entscheidung zum pädiatrischen Forschungsprogramm (PIP): Jyseleca, Figoratinibmaleat, Entscheidungsart: PM: Entscheidung über Änderungen eines vereinbarten PIP-Antrags, Therapiegebiet: Erkrankungen des Bewegungsapparates und des Bindegewebes, PIP-Nummer: EMA/PE/0000232302

Alfasigma S.p.A.

Medizinische Informationen July 2, 2026

Vollstaendiger Artikelinhalt

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

Productos relacionados con este articulo

Estos productos se asociaron automaticamente a partir del titulo, el resumen y el contenido del articulo.

Preguntas frecuentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Filgotinib – Comprar en línea.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.